The alleged problems with a major clinical trial examining Pfizer’s COVID-19 vaccine trial are being probed, a contract company involved in the research has confirmed. Ventavia Research Group operated several of the trial sites in the fall of 2020. Brook Jackson worked for the company during this time. She told the British Medical Journal (BMJ) that the trial was riddled with issues, including the falsification of data. Jackson said she alerted the Food and Drug Administration (FDA) to the problems she witnessed and was fired within hours of doing so. Ventavia confirmed to The Epoch Times that it employed Jackson for two weeks last year. Lauren Foreman, director of business development and communications, said in an email that Ventavia is investigating the allegations from Jackson. “Ventavia takes research compliance, data integrity, and participant safety very seriously and stands behind its important work supporting the development of lifesaving vaccines and is …